Bellicum Pharmaceuticals

173 articles about Bellicum Pharmaceuticals

• Bellicum Announces Clinical Data On BPX-501 At Presidential Symposium Of The 22nd Congress Of The European Hematology Association

  6/23/2017

• Bellicum Announces Management Changes

  5/16/2017

• Bellicum Reports First Quarter 2017 Financial Results

  5/9/2017

• Bellicum Announces Late-Breaking Presentation Of Dual-Switch CAR-T / TCR Technology At AACR

  4/4/2017

• Bellicum Announces Closing Of Public Offering

  3/30/2017

• Bellicum Announces Pricing Of Public Offering Of Common Stock

  3/24/2017

• Bellicum Announces Proposed Public Offering Of Common Stock

  3/23/2017

• Bellicum Provides Operational Update And Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2016

  3/14/2017

• Bellicum To Report Fourth Quarter And Full Year 2016 Financial Results And Host Conference Call And Webcast On March 13, 2017

  3/6/2017

• Bellicum Presents Updated Clinical Results At 2017 BMT Tandem Meetings On BPX-501 In Orphan Inherited Blood Disorders And Hematologic Cancers

  2/23/2017

• Bellicum Announces Initiation Of Patient Dosing With Controllable CAR T-Cell Product Candidate

  2/21/2017

• Genentech's Oncology Boss Jumps Ship to Helm Bellicum

  2/1/2017

• Bellicum Presents Clinical Results To Date Of BPX-501 Pediatric Program And Provides Regulatory Update At Investor Event During American Society of Hematology Annual Meeting

  12/6/2016

• Bellicum Announces GoCAR-T and GoTCR Preclinical Presentations at the American Society of Hematology 2016 Annual Meeting

  12/6/2016

• Bellicum Announces Updated Clinical Data From BPX-501 Study In Children With Primary Immune Deficiencies And Hemoglobinopathies

  12/5/2016

• Bellicum Announces GoCAR-T And GoTCR Preclinical Presentations At The American Society of Hematology 2016 Annual Meeting

  12/5/2016

• Bellicum Recommended For $16.9 Million Award From The Cancer Prevention And Research Institute Of Texas

  11/17/2016

• Bellicum Reports Third Quarter 2016 Financial Results

  11/10/2016

• Bellicum Announces Data Presentations On Lead Product Candidate BPX-501 And CAR-T And TCR Programs At The 58th American Society of Hematology Annual Meeting

  11/3/2016

• Bellicum And Ospedale Pediatrico Bambino Gesù Announce Expanded Collaboration To Develop Novel CAR T And TCR Cell Therapies Engineered With CaspaCIDe

  11/1/2016